Management of Women with Surgically Staged 1 Uterine Papillary Serous Cancer

Table 5

Recurrence rate by adjuvant treatment and stage of disease.

Author

Observation

Radiation

Chemotherapy

CT+RT

1A

1B

1C

1A

1B

1C

1A

1B

1C

1A

1B

1C

Bancher-Todesca et al. [42]

0/1

0/1

0/1

Bristow et al. [28]

1/ 4

1/1

Carcangiu et al. [33]

0/1

1/ 2

1/10

Dietrich et al. [34]

0/7

2/17

1/5

Elit et al. [35]

2/19

3/7

0/1

0/5

3/5

Fader et al. [36–38]

3/19

4/9

3/5

1/5

2/9

2/6

2/27

5/47

3/15

Fields et al. [32]

0/2

3/12

2/2

Gallion et al. [22]

0/3

0/1

1/1

0/0

4/4

1/2

Gehrig [44]

2/6

Huh et al. [29]

1 /3

0/6

1 /3

0/2

0/3

0/2

0/1

Low et al. [45]

0/1

1 /6

0/2

Piura et al. [46]

1 /2

0/1; 1DOC

0/3; 1DOC

1/1

0/1

0/2

Thomas et al. [41]

0/11

0/3

0/1

Elit et al.*

0/3

0/4

1/1

0/2

0/1

1/1

0/1

0/5

0/3

Total

8/64

8/19

4/9

3/13

1/29

7/16

0/10

2/20

2/8

3/42

9/65

5/21

Percent

12.5%

42%

44%

23%

3%

43.7%

0

10%

25%

7%

14%

25%

Stage 1A

12.5%

23%

0

7%

Stage 1B

42%

3%

10%

14%

Stage 1C

44%

43.7%

25%

25%

*Data from Elit are not added to summary statistics as median followup is less than 24 months.